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Abstract. The localization and intracellular transport 
of major histocompatibility complex (MHC) class II 
molecules and lysosomal hydrolases were studied in 
I-Cell Disease (ICD) B lymphoblasts, which possess a 
mannose 6-phosphate (Man-6-P)-independent target- 
ing pathway for lysosomal enzymes. In the trans-Golgi 
network (TGN), MHC class II-invariant chain com- 
plexes colocalized with the lysosomal hydrolase cathep- 
sin D in buds and vesicles that lacked markers of clath- 
fin-coated vesicle-mediated transport. These vesicles 
fused with the endocytic pathway leading to the forma- 
tion of "early" MHC class II-rich compartments 
(MIICs). Similar structures were observed in the TGN 
of normal [3 lymphoblasts although they were less 
abundant. Metabolic labeling and subcellular fraction- 
ation experiments indicated that newly synthesized 
cathepsin D and MHC class II-invariant chain com- 
plexes enter a non-clathfin-coated vesicular structure 
after their passage through the TGN and segregation 
from the secretory pathway. These vesicles were also 
devoid of the cation-dependent mannose 6-phosphate 
(Man-6-P) receptor, a marker of early and late endo- 
somes. These findings suggest that in ICD B lympho- 
blasts the majority of MHC class II molecules are trans- 
ported directly from the TGN to "early" MIICs and 
that acid hydrolases can be incorporated into MIICs si- 
multaneously by a Man-6-P-independent process. 
M 
AJOR histocompatibility complex  (MHC)  1 mole- 
cules mediate the presentation of antigenic pep- 
tides by antigen presenting cells  (APCs)  to T 
lymphocytes. Almost all cell types express  MHC class I 
molecules,  which display a variety of cytoplasmically  de- 
rived peptides for presentation to CD8-positive T lympho- 
cytes. MHC class II molecules are found on a restricted set 
of cell types such  as B lymphocytes, macrophages, den- 
dritic cells including epidermal Langerhans cells, and thy- 
mic epithelial cells. MHC class II molecules bind peptides 
generated by the proteolysis of exogenous antigens for 
presentation to CD4-positive  T lymphocytes (reviewed in 
Cresswell, 1994). The MHC class II complex consists of ct 
and 13 chains that associate  in the endoplasmic reticulum 
(ER) with the 31-33-kD  invariant (I) chain (Marks et al., 
1990).  It  is  generally  accepted  that  the  association  of 
I-chain with MHC class II prevents the binding of endoge- 
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nous peptides present  in the ER lumen (Teyton et al., 
1990; Roche and Cresswell, 1991), and that it is required 
for the efficient exit of the complex from the ER (Layet 
and Germain, 1991; Viville et al., 1993; Elliott et al., 1994). 
After passage through the Golgi complex, the majority of 
MHC class  II-I-chain trimers  are  believed to  be  trans- 
ported directly to an endocytic compartment (reviewed in 
Neefjes et al., 1991; Harding and Geuze, 1993b; Cresswell, 
1994). In contrast to most cell surface proteins, MHC class 
II et and 13  chains  undergo a 2-3-h transport delay in a 
post-Golgi compartment before arrival  at the cell surface 
(Neefjes et al., 1990). During this period, I-chain is dissoci- 
ated from the c~13 dimer by proteolytic cleavage and is rap- 
idly degraded. A signal in the cytoplasmic tail of I-chain is 
necessary for the diversion of o~13-I-chain trimers from the 
constitutive secretory pathway (Claesson-Welsh  and Pe- 
terson, 1985; Bakke and Dobberstein, 1990; Lotteau et al., 
1990; Lamb et al., 1991; Anderson and Miller, 1992; Pie- 
ters et al., 1993). However, the pathway by which MHC 
class  II-I-chain complexes  exit  the trans-Golgi network 
(TGN) and are delivered to the endocytic pathway has not 
been described. 
We have previously  reported that in B lymphoblastoid 
cell lines the majority of intracellular MHC class II mole- 
cules reside in a set of compartments, collectively termed 
the  MIIC/MHC class  II  enriched  compartment,  which 
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they contain  acid  hydrolases  and  lysosomal membrane 
proteins, are acidic, and are positioned relatively late on 
the endocytic pathway (Peters et al.,  1991a,  1995; Geuze, 
1994; Riberdy et al., 1994).  The MIIC was postulated to 
represent the site at which newly synthesized MHC class II 
molecules enter the endocytic route and acquire antigenic 
peptides (Neefjes et al., 1990; Peters et al., 1991a; Kleijmeer 
et al., 1995). Indeed, MIICs have recently been shown to 
represent the major localization of HLA-DM (Sanderson 
et al., 1994; Marks et al., 1995; Nijman et al., 1995), a novel 
MHC class II product that plays a decisive role in peptide 
loading of the MHC class II molecules (Denzin and Cress- 
well, 1995; Sherman et al., 1995). Furthermore, a number 
of  studies  with  macrophages  and  B  lymphocytes have 
demonstrated  that  cell  fractions  with  biochemical  and 
morphological characteristics resembling the MIIC medi- 
ate both the catabolic production of immunogenic pep- 
tides (Harding et al., 1991; West et al., 1994) and their cou- 
pling to  MHC class  II molecules  (Harding  and  Geuze, 
1992, 1993a; Amigorena et al., 1994; Qiu et al., 1994; Tulp 
et al., 1994). However since the intraceUular MHC class II 
molecules in some murine B  lymphocytes have been re- 
covered in low density compartments positioned early in 
the  endocytic pathway, it is possible that there is func- 
tional diversity among the MIICs of different cell types 
(Amigorena et al., 1994; Barnes and Mitchell, 1995; Mitch- 
ell et al., 1995; Mellman et al., 1995). 
While considerable information is available concerning 
the trafficking of newly synthesized MHC class II mole- 
cules and the I-chain, little is known about the mechanism 
whereby acid  hydrolases are  packaged into  the  MIICs. 
The best documented pathway for soluble lysosomal en- 
zyme targeting is that mediated by the mannose 6-phos- 
phate  (Man-6-P)  recognition  system. The  N-linked  oli- 
gosaccharides  of newly  synthesized  lysosomal  enzymes 
acquire Man-6-P residues that serve as recognition signals 
for binding to either the cation-dependent Man-6-P recep- 
tor  (CD-MPR)  or  the  Man-6-P/IGF-II  receptor  in  the 
TGN (reviewed in Kornfeld and Mellman, 1989). Man-6-P 
receptors with bound enzyme are incorporated into Golgi- 
derived clathrin-coated vesicles (Geuze et al., 1985; Bleeke- 
molen et al., 1988; Griffiths et al., 1988; Brown, 1990; Klump- 
erman et al., 1993) and transported to acidified endosomal 
compartments, where the ligands are discharged for subse- 
quent packaging into lysosomes. 
However, lysosomal enzymes can also be delivered to 
lysosomes by  a  Man-6-P-independent  targeting mecha- 
nism. Patients with the autosomal recessive disorder termed 
I-Cell Disease (ICD) have severely reduced levels of the 
enzyme N-acetylglucosamine 1-phosphotransferase, which 
forms the Man-6-P moiety on newly synthesized lysosomal 
enzymes (Hasilik et al.,  1981; Reitman et al.,  1981).  Al- 
though this disorder results in severe cellular lysosomal 
enzyme deficiencies in many tissues, certain cell types in 
ICD patients, such as B lymphocytes, have nearly normal 
levels of lysosomal enzymes (Little et al., 1987; Okada et 
al., 1988; Tsuji et al., 1988). The targeting of newly synthe- 
sized lysosomal enzymes in an ICD B lymphoblastoid cell 
line occurs by a direct intracellular route (DiCioccio and 
Miller, 1991; Glickman and Kornfeld, 1993) and in at least 
one instance is dependent upon the selective recognition 
of amino acid sequences present in lysosomal enzymes but 
absent from related secretory proteins (Glickman and Korn- 
feld, 1993).  Therefore, human B  lymphoblasts appear to 
possess  two  separate  lysosomal enzyme targeting  path- 
ways. Since ICD B lymphoblasts lack the Man-6-P--depen- 
dent pathway, this cell line allowed us to specifically exam- 
ine  the  relationship  of the  alternate  lysosomal enzyme 
targeting pathway to the formation of the MIIC using both 
morphological and biochemical techniques. We found that 
the acid hydrolase cathepsin D  and MHC class II-I-chain 
complexes colocalize in TGN-associated buds and vesicles 
that lack ~/-adaptin,  a marker of clathrin-coated vesicles. 
Metabolic labeling and  subcellular fractionation experi- 
ments indicate that soon after exiting the TGN, newly syn- 
thesized cathepsin D and MHC class II-I-chain complexes 
enter a vesicular compartment resembling MIICs observed 
in whole cells. These findings indicate that in ICD B lym- 
phoblasts, acid hydrolases are incorporated into MIICs by 
a  process  that is  independent of the Man-6-P pathway. 
Further,  these  enzymes,  together  with  MHC  class  II- 
I-chain complexes, appear to be transported to MIICs via 
non-clathrin-coated vesicles. 
Materials and Methods 
Materials 
Distilled acrolein was from Polysciences Inc. (Warrington, PA). Protein A 
and bovine serum albumin (BSA) were conjugated to colloidal gold parti- 
cles as described (Slot and Geuze, 1985).  EXPRE35S35S protein labeling 
mix was from DuPont-NEN (Boston, MA). [3H]UDP-galactose, ECL sys- 
tem, and Amplify fluorographic reagent were from Amersham (Arlington 
Heights, IL). Protein A-agarose was from Repligen Corp. (Cambridge, 
MA). Endoglycosidase H and swainsonine were from Boehringer Mann- 
helm Corp. (Indianapolis, IN). Hygromycin B was from Calbiochem Nova- 
biochem  (La  Jolla,  CA).  Percoll  was  from  Pharmacia  LKB  Nuclear 
(Gaithersburg, MD). All other chemicals were from Sigma Chemical Co. 
(St. Louis, MO). 
Cells and Antibodies 
The human B  lymphoblastoid cell line (BLCL) JY was obtained from 
American Type  Culture  Collection (ATCC)  (Rockville, MD) and was 
maintained in RPMI 1640,  10%  heat-inactivated fetal calf serum (FCS; 
Hazleton Biologics, Lexena, KS), 100 U/ml penicillin, 100 U/ml strepto- 
mycin at a density of 3-5 x  105/ml in a humidified 5% CO2 atmosphere. A 
B lymphoblastoid cell line derived from an ICD patient (Little et al., 1987) 
was kindly provided by Dr. A.L. Miller (University of California, San Di- 
ego) and was maintained in RPMI 1640, 10% bovine calf serum (Hyclone, 
Logan, UT), 100 U/ml penicillin, and 100 U/ml streptomycin under the 
same conditions. ICD BLCL transfected with cDNAs for human pepsino- 
gen or human cathepsin D  (Glickman and Kornfeld, 1993) were main- 
tained in the same medium supplemented with 200 U/ml hygromycin B. 
Rabbit antisera to human cathepsin D and the Man-6-P/IGF-II recep- 
tor have been described previously (Griffiths et al., 1988; Baranski et al., 
1990). Rabbit antisera to human pepsinogen were generated by injection 
of the purified protein (gift of Dr. I. Michael Samloff, UCLA). Rabbit an- 
tisera directed against human invariant (I-) chain were generated by injec- 
tion of KLH-conjugated peptides corresponding to residues 4-20 (IN) or 
191-210  (IC) of the 1-chain sequence (Strubin et al., 1984). IgG was puri- 
fied from immune sera using protein A-agarose. Hybridoma cells secret- 
ing the anti-MHC class I  monoclonal antibody W6/32  (Parham  et  al., 
1979)  were obtained from ATCC.  Hybridoma cells secreting the anti- 
MHC  class  II  monoclonal  antibodies HK14  (Shipp  et  al.,  1986)  and 
DA6.147 (Guy et al., 1982) were the kind gifts of Dr. M. Nahm (Washing- 
ton University School of Medicine) and Dr. B. D  Schwartz (Monsanto 
Chem. Corp., St. Louis, MO), respectively. Purified monoclonal antibod- 
ies to a-adaptin (AC1-Mll; Robinson, 1987), ~,-adaptin  (100.3; Ahle et al., 
1988), clathrin (TD.1; N~ithke et al., 1992), and 13 COP (M3A5; Allan and 
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E. Ungewickell (Washington University, St Louis, MO), F. Brodsky (Uni- 
versity of California, San Francisco), and T. Kreis (EMBL, Heidelberg, 
Germany), respectively. 
Other antibodies used for immunoelectron microscopy were raised in 
rabbits using human cathepsin D (Geuze et al., 1988), human CD63 (Met- 
zelaar et al., 1991), human MHC class I and class lI (Peters et al., 1991a), 
the Man-6-P/IGF-II receptor (Geuze et al., 1988),  synthetic peptides cor- 
responding to  the  CD-MPR  cytoplasmic domain (Schulze-Garg et  al., 
1993) and selected COOH-terminal (IC) and NH2-terminal (IN) peptides 
of human I-chain (Morton et al., 1995). 
Processing  for Immuno-Electron Microscopy 
Cells in logarithmic growth phase were centrifuged for 10 min at 500 g, 
4°C, and washed three times with 0.1 M Na phosphate, pH 7.4. Cells were 
gently resuspended to a  density of 2-5  ×  106/ml in the same buffer and 
fixed by the addition of an equal volume of 4% paraformaldehyde, 2% ac- 
rolein, 0.1 M Na phosphate, pH 7.4 (freshly prepared). After 2 h of con- 
stant mixing at room temperature, the fixed cells were washed three times 
with 0.1  M  Na phosphate, pH 7.4,  and stored in 2% paraformaldehyde, 
0.1 M Na phosphate pH 7.4, until further processing. 
BSA-5-nm gold conjugates to be used in endocytic uptake experiments 
were diluted to an optical density (at 520 nm) of 5 and dialyzed exten- 
sively against serum-free RPMI 1640 medium at 4°C. Cells (1 x  107) were 
centrifuged, washed three times in ice-cold serum-free RPMI 1640,  and 
resuspended in dialyzed BSA-gold at a density of ~5 ×  106/ml. After 10, 
30, or 60 min in a 37°C/5 % CO2 incubator, aliquots of cells were cooled on 
ice, centifuged 5 min at 500 g, 4°C, washed three times in ice-cold serum- 
free RPMI 1640,  and fixed in 2% paraformaldehyde, 1% acrolein as de- 
scribed above. 
Cells were embedded in 10% gelatin that was solidified on ice. Gelatin 
blocks with cells were immersed in 2.3 M sucrose in phosphate buffer for 
2 h  at 4°C and ultrathin cryosections were collected on a  mixture of su- 
crose and methyl cellulose to improve membrane morphology (Liou and 
Slot,  1994).  Ultrathin  cryosections  were  single  and  double  immuno- 
labeled as described (Slot et al., 1991) with 10- and 15-nm protein A-con- 
jugated colloidal gold probes (Slot and Geuze, 1985). 
Quantitation of lmmunogold and Endocytosis 
Quantitation of immunogold labeling for I-chain and MHC class II in JY 
and ICD B lymphoblasts was performed at a magnification of 12,000 di- 
rectly from the screen of the electron microscope as described in the leg- 
end to Table I. JY cells were used to quantitate possible colocalization of 
MHC class I, MHC class II, and the Man-6-P/IGF-II receptor with 7-adaptin 
in TGN/Golgi regions of 20 random cell profiles. Electron micrographs at 
a final magnification of 61,000 were taken from the TGN/Golgi regions in 
sections double-immunogold labeled for MHC class I, MHC class If, or 
the Man-6-P/IGF-II receptor with 5 nm gold and 3,-adaptin with 10 nm 
gold. Gold particles were allocated to ~-adaptin-positive TGN elements 
(mostly coated buds and vesicles), -t-adaptin-negative TGN elements, and 
Golgi cisternae. Membrane measurements were performed by counting 
intersections of membrane profiles with a  lattice  of squared lines on a 
transparent overlay, and revealed that 10%  of the TGN membrane was 
-t-adaptin coated. A total of 710, 677, and 462 gold particles were counted 
for MHC class I, MHC class II, and the Man-6-P/IGF-II receptor, respec- 
tively. The appearance of BSA-gold particles in MIICs was evaluated as 
described in the legend to Table II. Counting was done directly from the 
screen in the electron microscope at a magnification of 15,000. 
Metabolic Labeling and Subcellular Fractionation 
Cells (1-2  x  108) were washed twice in methionine-free, glutamine-free 
RPMI 1640,  10% dialyzed FCS, 25 mM Hepes-NaOH, pH 7.4,  100 U/ml 
penicillin, 100 U/ml streptomycin, and resuspended in this media at ~-1-2 
×  107 cells/ml. EXPRE35S35S  was added to 0.5 mCi/ml, and the cells were 
incubated for 10 min at 37°C and chased in the presence of 5 mM methio- 
nine for 15-20 min at 37°C. The cells were incubated for 1 h in a 20°C wa- 
ter bath, and then for various times in a  37°C/5% CO2 incubator as de- 
scribed in Results. Samples harvested at each time point were chilled on 
ice, and cells were pelleted and washed twice with ice-cold PBS and once 
with ice-cold vesicle homogenization buffer (VB: 0.14 M sucrose, 75 mM 
K acetate, 10 mM MES-KOH, 1 mM EGTA, 0.5 mM Mg acetate, pH 6.6). 
All further operations were carried out at 4°C. Cells were resuspended in 
1.0 ml VB containing 1 mM PMSF, 0.25 TIU/ml aprotinin, and 1×  of a 
protease inhibitor cocktail containing 2 wg/ml (final) leupeptin, pepstatin 
A, chymostatin, and antipain and homogenized with 12 passes through a 
ball bearing homogenizer with a  0.0011"  clearance (Balch et al., 1984; 
manufactured by Stanford University Medical School machine shop). The 
homogenate was centrifuged for 10 min at 500 g in a Beckman J-6B centri- 
fuge, the postnuclear supernatant was decanted, and the pellet was resus- 
pended in 500 wl VB for a second round of homogenization. The pooled 
PNS fraction was spun for 20 s in a microfuge to pellet any residual cells 
and nuclei and layered on a 2.5-ml cushion of 0.25 M  sucrose in VB and 
centrifuged for 2 h at 120,000 g in a Beckman SW 55 rotor. The superna- 
tant was carefully aspirated, the walls of the tube blotted dry, and the pel- 
let resuspended in 300-400 V,1 VB plus protease inhibitors. In some exper- 
iments, membranes were collected on a 500-0.1 pad of 2.5 M  sucrose and 
harvested in a minimum volume of the above buffer. Aliquots of this frac- 
tion were loaded on a  10-90% D20 gradient prepared in a  13 ×  51 mm 
Ultra Clear tube by layering 500 IM each of 90, 75, 60, 45, 30, 20, and 10% 
D20 in VB plus protease inhibitors. Gradients were centrifuged for 30 
min at 45,000 g in an SW55 rotor. 13 320-pxl fractions were collected from 
the top (1 = Top), and pelleted material was solubilized in 320 Ixl VB plus 
0.5% TX100 (fraction 14). Fractions were used for immunoprecipitation, 
enzyme assay or immunoblotting as described elsewhere in Materials and 
Methods.  D20  concentration  in  fractions  was  determined  by  refrac- 
tometry and comparison to a standard curve. 
lmmunoprecipitation 
All operations were performed at 4°C. Subcellular fractions were diluted 
in 0.1 M Tris-HCl, 0.1 M NaCl, 1% Triton X-100, I mM PMSF, 0.1 TI U/ml 
aprotinin, 0.2% BSA, pH 8.0, briefly sonicated, and precleared by 1-h in- 
cubation with protein A-agarose with constant agitation. The supernatant 
from this incubation was collected, appropriate  antiserum or hybridoma 
culture supernatant was added, and the samples were incubated for 4-12 h 
with constant agitation. For irnmunoprecipitation with anti-cathepsin D 
and anti-pepsinogen antisera, samples were adjusted to 0.5% Na deoxy- 
cholate and 0.2%  SDS. 25 ixl of protein A-agarose was added, and the 
sample was incubated for an additional 60 rain with constant agitation. 
Agarose beads were pelleted and washed four times with 0.l M Tris-HCl, 
0.1 M NaCI, 1% Triton X-100, pH 8.0, and twice with 0.1 M Tris-HCl, pH 
8.0. The supernatants were decanted and cleared with a second round of 
protein A-agarose for additional rounds of immunoprecipitation. Beads 
were eluted with nonreducing (anti-cathepsin D and anti-pepsinogen) or 
reducing SDS sample buffer by heating at 100°C and separated on 10 or 
12% SDS-polyacrylamide gels (Laemmli, 1970).  Gels were fixed, impreg- 
nated with Amplify, dried,  and fluorographed using Kodak XAR film. 
Radioactive bands were quantitated by excision and scintillation counting 
as described previously (Glickman and Kornfeld, 1993) or by densitomet- 
ric scanning with a Molecular Dynamics Personal Densitometer (Sunny- 
vale, CA). Both methods gave similar results. 
Immunolabeling of SubceUular  Fractions 
Velocity gradient fractions (typically fractions 2 through 8) were pooled, 
diluted two- to threefold with the appropriate homogenization buffer plus 
protease inhibitors and layered on a  1 ml pad of 2.5 M  sucrose, 25 mM 
Hepes-KOH, pH 7.2, in a 14 ×  89-mm Ultra Clear tube. This sample was 
centrifuged for 3 h at 150,000 g, 4°C, and membranes collecting on the pad 
were harvested in a minimum volume and fixed in 2% paraformaldehyde, 
1% acrolein, 0.1 M Na phosphate, pH 7.4, at room temperature. The fixed 
sample was stored in microfuge tubes precoated with 1% BSA until fur- 
ther  processing. For  double-immunogold labeling,  fixed  samples were 
concentrated at 12,000 g for 5 min. Samples of 2 ILl were put on grids and 
were allowed to adhere to the supporting film on the grids for 15 min in a 
moistened  environment  to  prevent  drying.  Immunolabeling was  per- 
formed as described above. 
Assays and Miscellaneous Methods 
13-Hexosaminidase, ct-glucosidase II (Little et al., 1987), and mannosidase 
II were assayed using 1 mM of the appropriate 4-methylurnbelliferyl sub- 
strate at pH 4.5, 7.0, and 6.0, respectively, in the presence of 0.1% Triton 
X-100. Fluorescence was measured on an Aminco fluorimeter. Mannosi- 
dase I! activity was calculated as the amount of substrate hydrolysis inhib- 
ited by 10 I~M swainsonine (Bischoff and Kornfeld,  1984).  Galactosyl- 
transferase activity was assayed as described in Goldberg and Kornfeld 
Glickman et al. The MHC H Compartment  771 (1983). Protein was assayed with the Bio-Rad (Bio-Rad Labs., Richmond, 
CA) dye reagent using bovine serum albumin as a standard. 
For  Western  blotting,  proteins  were  precipitated  with  chloroform/ 
methanol (Pohl, 1990), resuspended in reducing SDS sample buffer, elec- 
trophoresed on SDS-PAGE minigels (Laemmli, 1970), and blotted onto 
nitrocellulose using a Bio Rad miniblotter. Blots were blocked overnight 
in 20 mM Tris-HCl, 150 mM NaCI, 0.1% Tween 20 (TBST) plus 5% dry 
milk, and incubated for 2 h with the appropriate dilution of primary anti- 
body in TBST, 0.5% dry milk. The blots were washed, incubated with ap- 
propriate HRP-conjugated secondary antibodies, washed, and developed 
with chemiluminescent reagents (Amersham) according to the manufac- 
turer's instructions. 
Results 
ICD B Lymphoblasts Have Typical MIICs 
When the distribution of MHC class II molecules in a hu- 
man B lymphoblastoid cell line (JY) was examined in im- 
munogold labeled cryosections, the  molecules were pre- 
dominantly located at the plasma membrane (64% of the 
total) and in MIICs (32%  of the total; Table I). By con- 
trast, 1-chain was mostly located in the ER (43% of the to- 
tal), the Golgi complex including the TGN (28%) and in 
MIICs  (27%)  and  was  undetectable  at  the  cell  surface. 
Thus, the distribution of MHC class II and I-chain mole- 
cules showed a major overlap in the TGN and in MIICs, 
confirming that I-chain is a  good marker for the biosyn- 
thetic pathway taken by MHC class II molecules en route 
to the plasma membrane (Pieters et al., 1991; Neefjes and 
Ploegh, 1992). 
As shown in most of the figures and especially in Figs. 1 
A, and 2, B and C, ICD B lymphoblasts also exhibited nu- 
merous MIICs with  internal  membrane sheets  and vesi- 
cles. The distribution of I-chain and MHC class II in ICD 
B cells was almost identical to that found in JY cells (Ta- 
ble I). As previously observed in JY cells (Peters et al., 
1991a), the MIICs in ICD B cells contained the lysosomal 
membrane protein CD63, were devoid of both of the Man- 
6-P receptors, and accumulated the weak base DAMP, in- 
dicating that their content is acidic (not shown). The MIICs 
that contained I-chain were small, irregularly shaped and 
were usually located close to the Golgi complex (Figs. 1 A, 
2 B, and see Fig. 10, A and B). These MIICs can be recog- 
nized by their morphology often showing an empty space 
surrounded by a cisternae with internal vesicles (Figs. 2 B 
and 10 B). These structures likely represent forming MIICs. 
MIICs  lacking  I-chain  were  larger  and  often  exhibited 
membrane  sheets  in  their  lumens  (Figs.  1 A  and  2  B). 
Mixed multivesicular and  multilaminar MIICs were also 
present (Fig. 2 B).  Classical lysosomes, which had amor- 
phous contents and did not label for MHC class II mole- 
cules, were also present  (Fig.  1 A; see also Harding and 
Geuze, 1993a). Endosomes lacked MHC class II- and I-chain 
labeling and were scarce in both JY and ICD B  lympho- 
blasts.  Since  I-chain  is  rapidly  degraded  after  passage 
Table L Distribution of lnvariant Chain and MHC Class H in 
Normal (JY) and ICD B Lymphoblasts 
JY  ICD 
I-chain  MHC class II  /-chain  MHC class tl 
%  % 
ER  43  -  45  4 
Golgi  9  -  9  - 
TGN  19  3  15  2 
MIIC  27  32  24  20 
Vesicles  2  1  7  - 
PM  -  64  -  74 
Cryosections of JY cells and ICD B lymphoblasts were single-labeled with an anti- 
body against the NH  2 terminus of 1-chain or with anti-MHC class I! and 10-nm pro- 
tein A-gold. Gold particles were counted in the electron microscope at a magnification 
of 12,000. 20 random cell profiles of each cell type were evaluated. The total numbers 
of gold particles counted for I-chain and MHC class II were 1656 and 6062 in JY cells 
and 909 and 5141 in ICD B cells, respectively. Background labeling on companion 
sections labeled with anti-amylase antibodies amounted to 3% of this total and was 
subtracted for each compartment.  The values represent percentages of total gold parti- 
cles counted.  ER, endoplasmic reticulum; PM, plasma membrane;  TGN, trans-Golgi 
network. 
through  the  Golgi  complex  (Neefjes  and  Ploegh,  1992; 
Riberdy et al., 1994; Morton et al., 1995), we conclude that 
the small, irregularly shaped MIICs with detectable I-chain 
labeling represent newly formed, "early" MIICs and that 
the larger, more peripheral structures lacking I-chain are 
more mature, "late" MIICs. 
MHC Class H Localization in the TGN 
of ICD B Lymphoblasts 
To further investigate the structural relationship between 
the early MIICs and the TGN, we processed cryosections 
according to a modified procedure (Liou and Slot, 1994) 
that results in a sharper visualization of membranes than 
was previously possible. Fig.  1 B  shows small, irregularly 
shaped MIIC profiles located amidst membranes labeled 
for  the  Golgi  clathrin-coated  vesicle  protein  ~/-adaptin 
(Ahle  et  al.,  1988).  Membrane-associated  ~/-adaptin  is 
found  almost  exclusively  in  the  TGN  (Robinson,  1987; 
Ahle et al., 1988;  Geuze et al., 1992; Robinson and Kreis, 
1992), and consequently is a marker for a portion of the 
TGN.  Some of the  MIIC profiles  are  closely associated 
with ~-adaptin-labeled tubules (Fig. 1 B, arrowheads), in- 
dicating  that  these  structures  are  related  to  the  TGN 
rather than endosomes or some other compartment. ~-adap- 
tin  was  rarely  detectable  on  the  MHC  class  II-positive 
structures themselves, but was often present on buds and 
vesicles adjacent to them (Figs. 1 B and 3). The small 1-chain- 
positive  multivesicular  MIICs  near  the  Golgi  often  ap- 
peared to be fusing with each other and with multilaminar 
MIICs that lack I-chain (Fig. 1 A). 
Quantitation  of double-labeled cryosections of JY cells 
revealed a similar segregation between MHC class II mol- 
Figure 1.  Localization of MHC class II in [CD B lymphoblasts. (A) Golgi area with a stack of Golgi cisternae (G) and TGN (T) showing 
many I-chain-positive vesicles and a possible fusion profile (arrowheads) between an early MIIC with MHC class II labeling and abun- 
dant I-chain labeling and a later MIIC with only MHC class II labeling. L, lysosome. (B) Golgi complex (G) and extensive trans Golgi 
area showing several MIICs (asterisks),  some of which are connected to TGN elements (arrowheads) that are labeled for -y-adaptin. Ab- 
breviations used throughout the figures are: Ad, ~-adaptin; CD, cathepsin D; CI H, MHC class II; Clat, clathrin; IC, COOH-terminal (lu- 
menal) epitope of invariant chain; IN, NH2-terminal (cytoplasmic) epitope of invariant chain; MPR, cation-dependent mannose 6-phos- 
phate receptor. The numbers following each abbreviation refer to the size of the gold particle used, in nm. Bars, 0.1 Ixm. 
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of the  anti-MHC  class  II particles in  the  Golgi regions 
were  localized  to  ~/-adaptin-positive  TGN  membranes, 
whereas  84%  were  present  in  ~/-adaptin-negative  TGN 
membranes and 14% were in the Golgi stack. The corre- 
sponding values for MHC class I, which is transported to 
the cell surface by the constitutive secretory pathway and 
is segregated from MHC class II molecules in the TGN 
(Neefjes et al., 1990; Peters et al., 1991a), were 2, 48, and 
50%,  respectively. By contrast,  13%  of the  total Golgi- 
associated Man-6-P/IGF-II receptor molecules were pres- 
ent on ~/-adaptin-positive TGN membranes (mostly coated 
buds and vesicles), 76% occurred over ~/-adaptin-negative 
TGN, and 11% were found in the Golgi stack. These re- 
suits indicate that in B lymphoblasts, the Man-6-P/IGF-II 
receptor is concentrated relative to other proteins in -y-adap- 
tin-positive  TGN  coated  buds,  as  found  previously  in 
hepatoma  cells  (Klumperman et  al.,  1993),  while MHC 
class II molecules are excluded from these structures. In 
normal cells, therefore, newly synthesized lysosomal en- 
zymes bound to the Man-6-PIIGF-II receptor should not 
cosegregate with MHC class II molecules in the TGN. 
Cathepsin D Colocalization with MHC Class H 
In preliminary experiments, we found that the level of en- 
dogenous cathepsin D  in B  lymphoblasts was too low to 
allow  reliable  localization  of this  marker  in  the  TGN, 
although late MIICs and classical lysosomes contained de- 
tectable amounts of this acid hydrolase. Consequently, to 
study the localization of cathepsin D  in the TGN and in 
early MIICs, we used ICD B lymphoblasts that transfected 
with  the  human  cathepsin  D  cDNA.  These  transfected 
cells sort cathepsin D to lysosomes with about the same ef- 
ficiency as nontransfected cells (Glickman and Kornfetd, 
1993).  Fig.  2  shows  that  early MIIC  profiles associated 
with  the TGN contain cathepsin D  together with MHC 
class II (Fig. 2, A and C) and I-chain (Fig. 2 B). As was ob- 
served for MHC class II, cathepsin D  did not colocalize 
with ~/-adaptin in the TGN (Fig. 3, A and B). Thus, I-chain 
and  MHC class  II-positive structures  appear  to acquire 
cathepsin D while still associated with the TGN or shortly 
thereafter. 
Identification of lntraceUular Vesicles 
Bearing Cathepsin D and MHC Class II-lnvariant 
Chain Complexes 
To document the cotransport of MHC class II molecules 
and  cathepsin  D  further, we  attempted  to  isolate post- 
Golgi vesicles containing one or both of the newly synthe- 
sized proteins. To do this,  cathepsin D-transfected ICD 
lymphoblasts were labeled with 3SS-methionine for 10 min, 
chased for 15 min at 37°C, and incubated at 20°C for i  h to 
accumulate labeled proteins in the Golgi. The lymphoblast 
cultures were then incubated  for various times  at 37°C, 
and the cells were collected and homogenized. Total cellu- 
lar membranes were fractionated on 10-90% D20 velocity 
gradients, which separate membranes on the basis of sedi- 
mentation coefficient and have been used to resolve small 
vesicles  and  larger  organelle  fragments  (Pearse,  1982; 
Woodman and Warren, 1991). The velocity gradient frac- 
tions were then immunoprecipitated with anti-cathepsin D 
antisera. When the lymphoblasts were held at 20°C,  the 
great majority of radiolabeled procathepsin D  pelleted to 
the  bottom  of the  gradient  and  very little  secretion  of 
cathepsin D occurred (Fig. 4 A). After a 30-min incubation 
at 37°C, a significant proportion (34 _  2% over three sepa- 
rate  experiments; see Fig.  6)  of cellular procathepsin D 
was recovered in fractions 2 through 8, in the upper por- 
tion  of the  gradient  (Fig.  4  B).  Cathepsin  D  secretion 
could now be detected (lane M), indicating that exit from 
the TGN via the constitutive secretory pathway was occur- 
ring. The procathepsin D  molecules in these slowly sedi- 
menting fractions had an electrophoretic mobility identi- 
cal to secreted procathepsin D, indicating that they were 
sialylated and were either in or had passed  beyond the 
TGN (see Glickman and Kornfeld, 1993). The proportion 
of radiolabeled  cathepsin  D  associated  with  fractions 2 
through 8 was maximal at 90 min after the shift to 37°C 
and declined thereafter (Fig. 4, C and D  and Fig. 6). For 
the duration of the experiment, sialylated procathepsin D 
was  the  only  cathepsin  D  species  associated  with  the 
slowly sedimenting fractions. Nonsialylated procathepsin 
D  located in the ER and Golgi stack and the mature and 
heavy chain forms of cathepsin D that are generated in en- 
dosomal or lysosomal compartments (Gieselmann et al., 
1983) were found almost entirely in the pellets of these 
gradients (Fig. 4, C and D). All forms of cathepsin D  ana- 
lyzed on velocity gradients were resistant to proteinase K 
digestion in the absence of detergent (results not shown), 
indicating that they had been isolated inside sealed mem- 
brane compartments. These results indicate that after exit- 
ing the TGN but before arriving at the lysosome, cathepsin 
D  passes  transiently  through  an  intermediate  compart- 
ment that is detectable by velocity gradient centrifugation. 
When we analyzed the distribution of MHC class II spe- 
cies in D20 velocity gradient experiments similar to those 
described above, we found that, as  for procathepsin D, 
MHC  class  II-I-chain  complexes  appeared  primarily  in 
fractions 2 through 8 only after removal of the 20°C block 
(Fig. 5, A  and B). The reduced intensity of the I-chain 
band relative to the MHC class II ct chain band in these 
fractions compared to that present in the total membrane 
fraction (Fig. 5 B, lane 7) suggests that some dissociation 
of I-chain from MHC class II had occurred. The associa- 
tion of MHC class II molecules with these fractions was 
Figure 2.  Localization of cathepsin D in transfected ICD B lymphoblasts. (A) Two MIIC-like structures, closely associated with the 
trans-Golgi and labeled for both cathepsin D and MHC class II. G, Golgi complex. (B) trans-Golgi area showing several MIIC-like com- 
partments, three of which are of the multivesicular type (1, 2, 3) and contain labeling of both cathepsin D and 1-chain  NH2 terminus. MIICs 
1 and 3 located closest to the TGN (T) show the most intense labeling for I-chain, are irregularly shaped and represent the early type of 
MIIC. The mixed multivesicular and multilaminar MIIC (4) only shows cathepsin D and is a late MIIC. Arrowheads point to small dou- 
ble-labeled vesicles that may represent the immediate post-TGN transport intermediate in MHC class II and cathepsin D transport. (G) 
Golgi stack. (C) Survey of a trans-Golgi area with numerous MIICs labeled for cathepsin D and MHC class II. Note that the smaller and 
irregularly shaped MIICs are located closest to the Golgi stack (G). Bars, 0.1 I~m. 
Glickman  et al. The MHC H Compartment  775 Figure 3.  Cathepsin D-transfected  ICD B lymphoblasts. (A) Survey of Golgi area with TGN (T) and centrioles (C). The small MIICs 
(asterisks) contain labeling for cathepsin D. There is no overlap of cathepsin D and ~/-adaptin labeling. M, mitochondrion.  (B) Higher 
magnification of a similar area. The irregular MIICs (asterisks) only show cathepsin D while ~/-adaptin is localized to TGN tubules (T). 
Note the morphology of MIICs is suggestive of membrane folding. Bars, 0.1 ixm. 
maximal after 60 min incubation at 37°C (Fig. 6) but per- 
sisted over several hours and was marked by more com- 
plete dissociation from invariant chain  (Fig.  5  C). Thus, 
the slowly sedimenting gradient  fractions also  contain a 
post-Golgi intermediate compartment(s) in MHC class II- 
I-chain transport. 
The position of a variety of marker enzymes and pro- 
teins in the D20 velocity gradient is shown in Fig. 7. The 
fractions most strongly positive for procathepsin D  (Fig. 4 
C, fractions 3-7) contained 12% of the total protein, 13% 
of the Golgi marker galactosyltransferase, and 4% of the 
lysosomal marker  13-hexosaminidase recovered from the 
gradient  (Fig. 7 F). Immunoblots for clathrin (Fig. 7 A), 
the Golgi clathrin-coated vesicle protein ~/-adaptin (Fig. 7 
B)  and  the  plasma  membrane  coated  vesicle  protein 
et-adaptin (not shown) demonstrated that the distribution 
of these proteins paralleled that of sialylated cathepsin D 
(compare Fig. 7 B with 4 C). A  sample of purified bovine 
brain-coated vesicles sedimented to an equivalent position 
on a parallel gradient (results not shown). The remaining 
immunoreactivity for these proteins was found at the bot- 
tom  of the  gradient  and  presumably represents  clathrin 
coats assembled on Golgi and plasma membranes (Robin- 
son, 1987; Ahle et al.,  1988; Robinson and Kreis, 1992) or 
aggregates of clathrin-coated vesicles. A  small fraction of 
the total cellular Man-6-P/IGF-II receptor also cofraction- 
ated with the clathrin coat proteins (Fig. 7 C). The remain- 
ing receptor was recovered in the bottom of the gradient, 
most likely associated with the TGN, endosomes, and the 
plasma membrane. We also examined the distribution of 
The Journal of Cell Biology, Volume 132,  1996  776 Figure 4.  Velocity gradient analysis of cathepsin  D and glycopepsinogen transport in transfected ICD B lymphoblasts. Membranes from 
cathepsin  D (A-D) or glycopepsinogen  (E-F) transfected cells labeled as described  in the Results section were analyzed on D20 veloc- 
ity gradients.  Equal portions of all velocity gradient fractions were immunoprecipitated with antisera to cathepsin  D or pepsinogen,  as 
appropriate, and analyzed  by SDS-PAGE and fluorography.  Aliquots of culture  media (lanes M) and of total membranes (lanes  T) 
from each time point were immunoprecipitated in parallel to the velocity gradient fractions. Positions of procathepsin D (proCD), ma- 
ture cathepsin  D (CD), and cathepsin  D heavy chain (HC) are indicated.  (A) Cathepsin D, 20°C block (i.e., 0' at 37°C); (B) 30 min at 
37°C; (C) 90 min at 37°C; (D) 180 min at 37°C; (E) Glycopepsinogen,  20°C block (i.e., 0' at 37°C); (F) 30 min at 37°C. 
13-COP, a coat protein present primarily in pre-Golgi trans- 
port vesicles (Duden et al., 1991;  Serafini et al., 1991). In 
contrast to the  clathrin-coated vesicle proteins, the great 
majority  of  B-COP  immunoreactivity  was  found  at  the 
bottom of the  gradient  (Fig.  7  E).  The small amount of 
13-COP found near the top of the gradient cofractionated 
with galactosyltransferase activity (Fig. 7 F) and was clearly 
distinct from the distribution of the other markers. Only a 
small fraction of total cellular HLA DRa chain and 1-chain, 
as  assessed by immunoblotting,  was found in  fractions 2 
through 8 of the gradient (Fig. 7 D  and results not shown). 
Therefore, the sedimentation properties of the procathep- 
sin  D-  and  MHC  class  II-containing intermediate(s)  re- 
semble those of clathrin-coated vesicles but do not corre- 
spond to those of any other organelle marker tested. 
To determine the relationship of the MHC class II inter- 
mediates with clathrin-coated vesicles, the membranes iso- 
lated from the pooled velocity gradient fractions were ana- 
lyzed by immunoelectron microscopy. To avoid clustering 
of vesicles, diluted aliquots of fixed membranes were placed 
on grids and double-labeled with antibodies directed against 
the cytoplasmic domains of I-chain and the CD-MPR and 
against  clathrin  and  -y-adaptin.  As  shown  in  Fig.  8,  the 
I-chain labeling was found in vesicular structures that were 
devoid of -y-adaptin, CD-MPR or clathrin labeling (Fig. 8, 
A-C, respectively). The ~/-adaptin and clathrin were present 
only on small vesicles bearing a  morphologic coat while 
the CD-MPR was found on these structures as well as on 
larger, vesicular structures. In an attempt to localize cathep- 
sin D  in the content of the vesicles, we immunolabeled ul- 
trathin cryosections of the fractions but were unable to de- 
tect cathepsin D  because of technical difficulties. 
To determine  whether  constitutively secreted proteins 
also  moved through  the  same  structures,  we  performed 
similar gradient fractionation experiments with glycopep- 
sinogen-transfected ICD lymphoblasts. After a 60-min in- 
cubation at 20°C, no secretion of glycopepsinogen had oc- 
curred  and  95%  of the  [35S]methionine-labeled  enzyme 
pelleted to the bottom of the D20 velocity gradient (Fig. 4 
E). At this time point, ~60% of cellular glycopepsinogen 
was Endo H  sensitive (not shown) and therefore had not 
reached the TGN. During the 30 min following warming of 
the culture to 37°C, 90%  of the cellular glycopepsinogen 
acquired Endo H  resistance and was secreted (Fig. 4 F). In 
contrast to cathepsin D, glycopepsinogen did not accumu- 
late  in  the  slowly sedimenting  fraction  during  this  time 
(Fig. 6). Therefore, glycopepsinogen, which traverses the 
secretory pathway,  is  secreted  without  appearing  in  the 
Glickman et al. The MHC H Compartment  777 Figure 5.  Velocity gradient analysis of MHC class II transport in 
ICD B lymphoblasts.  Experimental details were similar to those 
in Fig. 4, except that gradient fractions were immunoprecipitated 
with the anti-HLA DR monoclonal antibody HK14. Positions of 
MHC class II ct and 13 chains and I-chain are indicated.  (A) 0 min 
at 37°C; (B) 60 min at 37°C; (C) 180 min at 37°C. 
gradient fractions that transiently accumulate procathep- 
sin D  and MHC class II (Fig. 6). Similarly, newly synthe- 
sized MHC class I molecules, another marker of the con- 
stitutive  secretory  pathway,  did  not  accumulate  in  the 
velocity gradient  fractions  above their  steady-state level 
(Fig. 6). 
MHC Class H Localization in Normal B Lymphoblasts 
As in ICD B  lymphoblasts, JY cells showed close associa- 
tions of MHC class II-positive structures and the TGN. A 
favorable section through a Golgi area is depicted in Fig. 9 
showing  three  instances  of  membrane  connections  be- 
tween TGN tubules and MHC class II-positive buds and 
vesicles. Labeling for ~-adaptin is absent from these pro- 
files, but is present at other TGN subdomains. There is a 
close similarity between the  TGN-associated MHC class 
II-positive structures present in the JY lymphoblasts and 
those in ICD B lymphoblasts (compare Fig. 9 with Figs. 2 
B  and  10,  A  and  B).  ~/-Adaptin-coated  vesicles  at  the 
trans-Golgi  side were negative for MHC class II (Fig. 9, in- 
set). These observations suggest that in normal B lympho- 
blasts, MHC class II can exit from the TGN in  a  similar 
fashion  as  in  ICD  B  lymphoblasts.  However, in  ICD  B 
lymphoblasts,  MHC  class  II-positive  buds  were  much 
more frequent. 
The Endocytic Tracer BSA-Gold Enters Early MIIC 
Previous studies (Peters et al., 1991a;  Harding and Geuze, 
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Figure 6.  Quantitation  of  velocity  gradient  results,  including 
those presented in Figs. 4 and 5. Open squares, procathepsin D; 
closed circles, glycopepsinogen;  open circles, HLA DR ct chain. 
Distribution of MHC class I heavy chain molecules  (open trian- 
gles) was determined by serial  immunoprecipitation of velocity 
gradient fractions  with the monoclonal antibody W6/32. Radio- 
activity  in  bands was  determined by excision  and  scintillation 
counting of gel slices, or by densitometric scanning of autoradio- 
graphs. The proportion of radiolabeled protein recovered in ve- 
locity gradient fractions 3 through 8 is plotted as a percentage of 
the  total recovered from the  gradient.  Where  error  bars  are 
given, values represent the mean -+ SD of three independent ex- 
periments. All other values are single determinations. 
1992,  1993a) have shown that MIICs are positioned late in 
the endocytic pathway, being labeled with endocytic trac- 
ers after 30 min or more of uptake. To identify the  site 
where  the  biosynthetic  pathway  of MHC  class  II mole- 
cules  and  the  endocytic route  intersect,  we  allowed  un- 
transfected ICD B lymphoblasts and JY cells to internalize 
the fluid phase endocytic marker BSA-gold for 10, 30, and 
60 min. The distribution of this tracer was then examined 
in cryosections labeled for I-chain and MHC class II. After 
10  min  of  uptake,  BSA-gold  was  found  at  the  plasma 
membrane of each cell type and in small endosomal vesi- 
cles that did not label for I-chain (results not shown and 
Table  II).  Quantitation  of  immunolabeled  sections  re- 
vealed that only 5% of BSA-gold-positive structures con- 
tained MHC class II at this time. After 30 min of uptake, 
endocytic  tracer  had  reached  the  MIICs.  Strikingly,  in 
both JY  and  ICD  B  lymphoblasts, endocytic  tracer was 
found preferentially in irregular I-chain-positive MIICs at 
this time point (Fig. 10, A  and B). Quantitation of double- 
immunolabeled cryosections (Table II) showed that whereas 
BSA-gold reached these I-chain-positive early MIICs be- 
tween  10  and  30  min  of uptake,  significant  amounts  of 
tracer reached I-chain-negative MIICs only after 60 rain. 
These results indicate that breakdown of 1-chain occurs af- 
ter  MHC  class  II molecules  have  entered  the  endocytic 
pathway, and  that  "mature" 1-chain-negative MIICs are 
positioned later on the endocytic pathway than are I-chain- 
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Figure 7.  Characterization of velocity gradient fractions.  (A-E) 
Equal portions of the indicated  fractions were separated by SDS- 
PAGE, blotted onto nitrocellulose,  and probed with antibodies 
against  the indicated  proteins:  (A) anti-clathrin  mAb TD.1; (B) 
anti-v adaptin mAbl00.3; (C) affinity-purified rabbit anti-Man-6- 
P/IGF-II receptor; (D) anti HLA DR cc chain mAb DA6.147; (E) 
anti [3-COP mAb M3A5. Bound antibody was detected with the 
appropriate horseradish  peroxidase-conjugated  secondary anti- 
bodies  and chemiluminescence.  Similar  results  for each marker 
were obtained in two to five independently run gradients.  (F) dis- 
tribution of marker enzymes. Results  are typical of at least three 
determinations for each assay. GalT, galactosyltransferase.  D20 
percentage in each fraction should be read on the scale to the left 
of the graph. 
positive MIICs. In accordance with previous observation 
in  normal B  lymphoblasts (Peters et al.,  1995),  these re- 
suits  suggest  that  in  ICD  B  lymphoblasts the  pathways 
traveled  by biosynthetic  MHC class-II and  endocytosed 
material intersect at a site in close proximity to the TGN, 
probably the irregularly shaped multivesicular early MIIC. 
Discussion 
In this study, the trafficking and localization of MHC class 
II, I-chain and cathepsin D  were examined in a  B  lympho- 
blastoid cell line derived from a patient with I-cell disease. 
While these cells are defective in the synthesis of the Man- 
6-P recognition  marker on  soluble  acid  hydrolases,  they 
are still able to selectively target these  enzymes to lyso- 
Table II. Appearance of  BSA-Gold Particles in MIIC'  s of  JY 
and ICD B Lymphoblasts 
JY  ICD 
Minutes of 
uptake  +I-chain  -I-chain  +I-chain  -I-chain 
10  2  -  -  - 
30  53  1  40  6 
60  57  14  48  28 
After the indicated times of continuous  uptake of 5 nm BSA-gold particles, cells were 
harvested and fixed, and cryosections  were double-immunogold  labeled  for I-chain 
and MHC class II with 10-nm and 15-nm gold particles, respectively.  For each time- 
point, MHC's with BSA-gold tracer in 50 random cell profiles were scored for label- 
ing of I-chain or for MHC class II only. The values represent numbers of MIIC's con- 
taining  ~racer which were positive  for MHC class  13 and I-chain (+I-chain) or for 
MHC class U only (-I-chain). 
somes by a Man-6-P-independent mechanism (DiCioccio 
and Miller,  1991;  Glickman and  Kornfeld,  1993).  Conse- 
quently the ICD B  lymphoblasts provided an opportunity 
to examine whether acid hydrolases are also delivered to 
the MIICs by an alternate targeting pathway. 
Immunoelectron  microscopy  of  ultrathin  cryosections 
revealed that ICD B  lymphoblasts possess MIICs similar 
to  those  previously observed in  normal  B  lymphoblasts 
(Peters et al., 1991a, 1995; Geuze, 1994), and that the over- 
all  distribution  of MHC class  II and  I-chain was  nearly 
identical in the two cell types. The Golgi region of ICD B 
lymphoblasts  contained  numerous  MHC  class  II-  and 
I-chain-positive profiles, some of which appeared to be in 
close association with membranes of the TGN as defined 
by  immunolabeling  for  -y-adaptin,  but  were  themselves 
negative for -y-adaptin. It is proposed that these  vesicles 
represent transport vehicles for newly synthesized  MHC 
class II. In the trans-Golgi  region, MIICs were observed 
that  labeled with  antibodies  against the  I-chain lumenal 
and  cytoplasmic domains  and  could  be labeled with  en- 
docytic tracers.  These  findings  indicate  that  the  biosyn- 
thetic pathway of MHC class II and the endocytic pathway 
intersect immediately after Golgi passage of MHC class-II 
in newly formed MIICs. These early MIICs then undergo 
a maturation process during which the I-chain is destroyed 
and more internal membranes are formed by infolding and 
internal  budding  of limiting  membrane.  Certainly  other 
mechanisms may exist for MHC class II- and  I-chain to 
exit the  TGN. Nevertheless, if this  interpretation  is cor- 
rect, it implies that the MHC class II- and I-chain can leave 
the  TGN  by  a  process  that  does  not  require  clathrin- 
coated vesicles. While similar profiles were observed in a 
normal B  lymphoblast cell line (JY), they were much less 
abundant. This suggests that the budding process that we 
describe here may be amplified in the ICD B lymphoblasts 
and perhaps represents a  less developed pathway in nor- 
mal human B lymphoblasts. 
In cathepsin  D-transfected  cells,  cathepsin  D  labeling 
was abundant in MHC class II- and I-chain-positive buds 
and  vesicles,  and  like  MHC  class II, was  largely absent 
from -¢-adaptin-positive regions of the TGN. However the 
MHC class II-positive structures labeled only weakly for 
glycopepsinogen (results not shown), a protein related to 
cathepsin D  that is largely secreted from transfected ICD 
B lymphoblasts (Glickman and Kornfeld, 1993). Although 
Man-6-P-dependent transport presumably plays a  role in 
the endosomal and lysosomal sorting of acid hydrolases in 
Glickman et al. The MHC H Compartment  779 Figure 8.  Morphology of velocity gradient fractions. Pooled D20 velocity gradient fractions (fractions 3 through 8; see Figs. 4, 5, and 7) 
from 109 ICD B lymphoblasts were concentrated and fixed as described  in Materials  and Methods and immunogold labeled with anti- 
bodies against ",/-adaptin, clathrin,  and the cytoplasmic domains of I-chain (IN) and the cation-dependent Man-6-P receptor (MPR). 
I-chain did not colocalize with -,/-adaptin (A), MPR (B), or clathrin (C). Bars, 0.1 ~m. 
normal  B  cells,  the  efficient  and  selective packaging of 
cathepsin D into MIICs in ICD B lymphoblasts shows that 
this process can occur independently of the Man-6-P tar- 
geting system. 
Since the above results raised the possibility that MHC 
class  II and  cathepsin  D  may exit  the  TGN  and  reach 
MIICs by a clathrin-independent transport process, we de- 
signed kinetic experiments to identify vesicular intermedi- 
ates in the transport of these molecules. These experiments 
showed that newly synthesized procathepsin D  and MHC 
class II transiently associate with membrane vesicles dis- 
tinguishable by their slow sedimentation on velocity gradi- 
ents.  Several  findings  support  the  contention  that  these 
vesicles derive from the  Golgi and carry endosomally or 
lysosomally targeted  procathepsin  D  and  MHC class II. 
First, sialylated procathepsin D  is the only form of cathep- 
sin  D  associated  with  this  fraction,  indicating  that  the 
cathepsin D  has passed through the trans-Golgi, where sial- 
ylation occurs, but  has not  reached the  lysosome, where 
the prosegment is cleaved (Gieselmann et al., 1983).  In ad- 
dition, the MHC class II heterodimers found in these frac- 
tions  also contain complex-type oligosaccharides  (results 
not shown) and are only partially complexed with I-chain, 
arguing for a  similar post-Golgi localization.  Second, the 
procathepsin D and MHC class II molecules only enter the 
vesicles after removal of the 20°C  block, which prevents 
proteins from exiting the Golgi. Third, we found that the 
fractions transiently  positive for procathepsin  D  are sig- 
nificantly depleted of markers for the endoplasmic reticu- 
lum, Golgi, and lysosomes, and  account for only a  small 
fraction  of  cellular  protein  and  [35S]methionine-labeled 
protein. 
The Journal of Cell Biology,  Volume 132, 1996  780 Figure 9.  trans-Golgi area in normal B lymphocytes (JY). Network of TGN tubules showing scarce labeling for ~/-adaptin (arrows) and 
abundant MHC class II labeling. The arrowheads indicate connections  between the tubules  and small MIIC-like profiles with internal 
membranes. (Inset) Another TGN subdomain showing distinct labeling for MHC class II and ~/-adaptin. Bars, 0.1 t~m. 
Even though the procathepsin D  and MHC class II mol- 
ecules are only transiently associated with the vesicles, this 
fraction can account for as much as 45%  of labeled pro- 
cathepsin D  and 37% of radiolabeled MHC class II, indi- 
cating  that  this  intermediate  lies  on  a  major post-Golgi 
transport pathway. Finally, these fractions do not accumu- 
late  glycopepsinogen  or  MHC  class  I  molecules  during 
their packaging in secretory vesicles, which are short-lived 
and difficult to detect except in cell-free assays (de Curtis 
and Simons, 1989; Tooze and Huttner, 1990). 
Immunoelectron microscopy of these fractions revealed 
the presence of vesicular structures that contained I-chain, 
but  lacked  the  markers of clathrin-coated  vesicles.  Fur- 
ther, the I-chain-positive vesicles were distinct from vesi- 
cles  containing  the  CD-MPR.  Since  the  CD-MPR  is  a 
marker of both early and late endosomes (Klumperman et 
al., 1993), this finding indicates that the vesicles containing 
I-chain are not typical endosomes. These results are con- 
sistent with the suggestion that in ICD B  lymphoblasts a 
significant portion of newly synthesized MHC class II and 
I-chain exits the TGN in non-clathrin-coated vesicles that 
fuse with and/or mature into MIICs without passing through 
Man-6-P receptor positive early and late endosomal struc- 
tures. While it is likely that the MHC class II and I-chain 
positive vesicles also contain newly synthesized procathep- 
sin D, it was not possible to detect the latter in these frac- 
tions by immunolabeling for technical reasons. 
The  proper sorting  of MHC  class  II molecules to  en- 
docytic compartments involves cytoplasmic tail sequences 
in  the  associated I-chain (Bakke  and  Dobberstein,  1990; 
Lotteau et al., 1990; Pieters et al., 1993). Interestingly, one 
I-chain cytoplasmic tail sequence implicated in its target- 
ing, an LI dipeptide, is related to the dileucine-based sort- 
ing signal found in the Man-6-P/IGF-II receptor and other 
proteins  (Letourneur  and  Klausner,  1992;  Johnson  and 
Kornfeld, 1992,  Chen et al., 1993). Although this sequence 
appears to be necessary for efficient entry of the Man-6-P/ 
IGF-II receptor into  Golgi-derived  clathrin-coated  vesi- 
cles, our results suggest that the invariant chain signal di- 
rects sorting by a  clathrin-independent  mechanism. Since 
MHC class II-negative cells were generally used to define 
the putative 1-chain-targeting signals, the manner in which 
I-chain directs endosomal targeting may differ when it is 
complexed with MHC class II molecules in  antigen-pre- 
senting cells. 
Calafat et al. (1994) have shown that the expression of 
wild-type MHC class II/I-chain complexes in human em- 
bryonal kidney 293 cells is sufficient to induce the forma- 
tion  of  multivesicular  endocytic  structures  resembling 
MIIC. These  structures  are  enriched  in  lysosomal mem- 
brane proteins and cathepsin D  but devoid of Man-6-P re- 
ceptors. The formation of the MIIC-like compartment was 
dependent on the transmembrane and cytoplasmic regions 
of the class II molecules. The ability of class II molecules 
Glickman et al. The MHC H Compartment  781 Figure 10.  BSA-gold internalization  into ICD B lymphoblasts. Cells were allowed to internalize  BSA coupled to 5-nm gold particles for 
30 min at 37°C. (A) An irregularly shaped MIIC with tracer in its content is associated with the TGN (T). I-chain is present in the Golgi 
stack, TGN, and in the MIIC. (B) Several irregularly shaped MIICs located close to the Golgi complex (G) labeled for both the lumenal 
and cytoplasmic domains of 1-chain and containing BSA-gold tracer. Bars, 0.1 I~m. 
to induce the formation of MIIC, possibly via aggregation 
involving  the  transmembrane  and  cytoplasmic domains, 
provides a possible mechanism for the formation of MHC 
class II enriched buds in the TGN. 
Recent  studies  have  suggested  that  MHC  class  II- 
enriched vesicles may represent a heterogeneous group of 
compartments (Barnes and Mitchell, 1995; Mitchell et al., 
1995; Mellman et al., 1995; Peters et al., 1995). Thus Amig- 
orena et al.  (1994)  have described in murine B  lympho- 
blasts the "class II vesicles" or CIIVs that are enriched in 
MHC class II, but devoid of lysosomal membrane mark- 
ers. The CIIVs also contain low levels of transferrin and 
Man-6-P  receptors,  markers of the  recycling endosomal 
pathway that are absent in MIIC. The CIIV may represent 
the early MIIC subclass (Peters et al., 1995).  On the other 
hand, if the MHC class II-enriched compartments prove to 
be truly heterogeneous, then it would not be unexpected 
that a  variety of delivery pathways are used to transport 
newly  synthesized  MHC  class  II to  these  structures.  In 
fact,  several studies  have  demonstrated  the  presence  of 
small amounts of I-chain and MHC class II-I-chain com- 
plexes on the cell surface, and it has been shown that these 
molecules  are  rapidly internalized  (Wraight  et  al.,  1990; 
Roche et al., 1993). The molecules may have reached the 
cell surface by direct delivery from the TGN or indirectly 
following  targeting  to  early endosomes and  recycling to 
the  cell  surface.  Alternatively,  these  surface  molecules 
may be  derived  from MIICs that  fuse  with  the  plasma 
membrane.  Exocytotic  fusion  of  early  MIICs  with  the 
plasma membrane has recently been demonstrated  in  B 
cells  (Raposo et  al.,  1995).  It is difficult to estimate the 
fraction of newly synthesized MHC class II-I-chain com- 
plexes that traverse the cell surface. Studies with an I-chain/ 
transferrin receptor chimera containing the  I-chain cyto- 
plasmic tail and transmembrane region indicated less than 
20% of these molecules traffic via the cell surface (Odor- 
izzi et al., 1994). It seems likely that MHC class II-I-chain 
complexes are targeted to the MIICs by both routes, with 
the intracellular pathway being the predominant one. Cas- 
tellino and Germain (1995) have presented evidence that 
in splenic B  lymphocytes at least some of the newly syn- 
thesized MHC class II is initially delivered to low density, 
early endosomal compartments whereas Xu et al.  (1995) 
and Benaroch et al. (1995) using different cell types have 
suggested that the MHC class II molecules are transported 
from the TGN directly to the MIIC. These latter findings 
are consistent with the  results obtained with the  ICD B 
lymphoblasts. 
The observations concerning cathepsin D  trafficking in 
the ICD B lymphoblasts provide insight into the Man-6-P- 
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the  newly  synthesized  acid  hydrolases  acquire  Man-6-P 
residues that allow binding to the Man-6-P receptors and 
packaging in clathrin-coated vesicles in the TGN. The re- 
ceptor-ligand  complexes  are  transported  to  endosomal 
compartments where the low pH induces the release of the 
acid hydrolases (Kornfeld and Mellman, 1989; Ludwig et 
al., 1991; Klumperman et al., 1993). The soluble acid hy- 
drolases  are then transported  to lysosomes  and presum- 
ably to MIICs whereas the Man-6-P receptors  recycle to 
the TGN for additional rounds of transport or to the cell 
surface. As shown in this study, cathepsin D  and probably 
other acid  hydrolases transported  by the Man-6-P-inde- 
pendent pathway appear to reach the endocytic pathway 
in  non-clathrin-coated  vesicles  that  also  contain  MHC 
class II and I-chain. As in the case of the transport of the 
MHC class II molecules, we cannot exclude the possibility 
that a  portion  of the  acid  hydrolases  are  packaged  into 
clathrin-coated vesicles in the TGN. The "lysosomal" lo- 
calization of soluble  acid  hydrolases  transported  by  the 
Man-6-P-independent  pathway may reflect  their passive 
flow from MIICs into lysosomes, or it may result from the 
further maturation of MIICs  as  they lose  MHC  class  II 
molecules.  MHC class  II  molecules  in this compartment 
acquire antigenic peptides after the dissociation of I-chain 
and  are  transported  to  the  cell  surface  (Raposo  et  al., 
1995). 
In  defining  the  site  where  exogenous  antigen  is  pro- 
cessed into peptides that can be loaded onto nascent MHC 
class II molecules, the early MIICs are of particular inter- 
est. Early MIICs contain cathepsin D  and probably other 
soluble acid hydrolases, have variable amounts of I-chain 
COOH-terminal epitope (Peters et al., 1995; this study) in- 
dicating I-chain breakdown, and are the first MIICs type 
that  can  be  labeled  with  an  endocytosed  tracer.  Thus, 
breakdown of endocytosed antigen and of I-chain may oc- 
cur simultaneously during maturation of MIICs, so that as 
soon as the binding grooves of the MHC class II molecules 
are freed from I-chain, properly sized peptides can bind. 
Although our studies have been confined to B  lympho- 
cytes,  a  number  of  observations  suggest  that  other  cell 
types may possess similar acid hydrolase-targeting mecha- 
nisms.  For instance, the cytolytic granules of cytotoxic T 
lymphocytes  share  many characteristics  with MIICs  and 
lysosomes,  including  membrane  sheets  and  vesicles  in 
their lumens, acidic lumenal pH, presence  of acid hydro- 
lases and lysosomal membrane proteins, absence of Man- 
6-P receptors,  and late position in the endocytic pathway 
(Peters  et  al.,  1991b).  Recently,  studies  on  human cyto- 
toxic T  cells have shown that two cell type-specific  pro- 
teases, granzymes A  and B, acquire Man-6-P residues but 
can be sorted to cytolytic granules by a Man-6-P-indepen- 
dent mechanism in ICD T cells (Griffiths and Isaaz, 1993). 
Further studies should reveal whether the cytolytic gran- 
ules and MIICs share a similar pathway of formation, and 
whether T  and B  lymphocytes possess a common Man-6- 
P-independent targeting system for acid hydrolases. 
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